Advanced search×

[Cutaneous manifestations of essential thrombocythemia. Erythromelalgia, ischemic acrocyanosis, livedo racemosa].

J J Bauerschmitz and J J Knop

Hautarzt 46(7):477-80 (1995) PMID 7672987

A case report is presented to illustrate the cutaneous manifestations in essential thrombocythaemia. Knowledge of the related skin lesions may lead to earlier detection of this myeloproliferative disorder. Treatment may prevent severe haemorrhagic or thrombotic complications. Erythromelalgia is causally related to thrombocythaemia; prompt relief of painful symptoms after treatment with aspirin is typical.

Version: za2963e q8za2 q8zb8 q8zc8 q8zdb q8ze7 q8zfa q8zg6
Buy PDF

Similar articles you may find interesting…

  1. JAK2 Mutation-Related Disease and Thrombosis.
    Alessandro M Vannucchi and Paola Guglielmelli

    Semin Thromb Hemost (2013) PMID 23633193

    We discuss about potential mechanisms that link mutated JAK2 with the thrombotic propensity of MPN and the clinical correlates; hopefully, novel information could result in better patient management. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA....
    Buy PDF
  2. Haemodialysis before emergency surgery in a patient treated with dabigatran.
    P Esnault, P E Gaillard, and B Prunet

    Br J Anaesth (2013) PMID 23650254

    We report the first case of perioperative management of a patient treated with dabigatran requiring haemodialysis before emergency surgery. A 62-yr-old woman visited the emergency department for a left bi-malleolar ankle fracture; she had a past medical history of severe ischaemic cardiomyopathy, al...
    Buy PDF
  3. Two CML patients who subsequently developed features of essential thrombocythemia with JAK2-V617F mutation while in complete cytogenetic rem...
    Yoo Jin Lee, Joon Ho Moon, and Sang Kyun Sohn

    Int J Hematol (2013) PMID 23613267

    The present report describes two chronic myelogenous leukemia (CML) patients with the JAK2-V617F mutation who were in complete hematologic and cytogenetic remission and subsequently developed clinical features of essential thrombocythemia under treatment with tyrosine kinase inhibito...
    Buy PDF